Recent changes in the terminology of a common reproductive health condition, previously known as polycystic ovarian syndrome (PCOS), to polyendocrine metabolic ovarian syndrome (PMOS) reflect ongoing efforts to capture the complexity of the condition. This adjustment aims at enhancing recognition and diagnosis, particularly among Black and Latina women, who statistically experience more severe symptoms and greater prevalence of the disorder compared to their white counterparts.
Bontle Moka-Moliki, a 32-year-old from Atlanta, exemplifies the struggles faced by those diagnosed with PMOS. After years of battling chronic pain linked to endometriosis and fibroids, Moka-Moliki received her PMOS diagnosis in 2024. She emphasizes the emotional toll of enduring daily pain, often compounded by feelings of despair, reflecting a broader issue within the medical community regarding the treatment of women of color.
Experts are hopeful that the rebranding to PMOS could lead to increased awareness and expedited diagnoses. Statistics indicate that women of color, particularly Black and Latina women, are twice as likely to suffer from PMOS yet often experience delays in diagnosis and treatment. This demographic not only faces unsympathetic healthcare responses but also navigates barriers related to access and financial support, potentially exacerbating the severity of their conditions.
The name change from PCOS to PMOS is pivotal in reshaping how this condition is perceived within medical literature. Medical professionals describe PMOS as not solely a reproductive condition but rather an endocrine disorder with broad implications, including impacts on metabolism, cardiovascular health, and mental well-being. This new classification is crucial for recognizing symptoms that extend beyond the ovaries, allowing for a more comprehensive treatment approach.
Helena Teede, a women’s health professor, noted that this change will facilitate better understanding and management of the condition over time. The prior focus on cyst presentation contributed to a lack of proper diagnosis, leaving many women, especially those in marginalized communities, suffering in silence.
Despite the prevalence of PMOS, it is estimated that more than 70% of individuals with the condition go undiagnosed. This issue is compounded by the absence of a standalone diagnostic test, leading to complexities in identifying PMOS among women of color. Current guidelines require patients to meet two of three criteria: irregular ovulation, hyperandrogenism, and the presence of ovarian cysts. However, a lack of awareness and education among health professionals about the condition contributes to misdiagnosis and delayed treatment.
Annterria Bruce, a women’s health nurse practitioner, points out that many physicians are still misinformed about PMOS, with a common misconception linking it exclusively to cystic growths. Bruce herself endured years before receiving her diagnosis, which was finally confirmed at 25, after suffering from symptoms since the age of 18. The challenges faced by women like Bruce highlight the urgent need for improved educational resources and training for healthcare providers.
The toll of PMOS extends beyond physical symptoms. Moka-Moliki and other women report severe emotional fluctuations, leading to heightened risks of mood disorders among those affected. The interplay between physical health and mental well-being underlines the importance of treating the whole person rather than focusing solely on the symptoms of the disorder.
Physician Margaret Lippincott emphasizes that the healthcare system has historically neglected the health of women of color, a trend that needs to be addressed if we are to improve health outcomes for these communities.
As healthcare advocate Andrea Medina-Alvarado highlights, while the name change to PMOS signifies progress, significant work remains to educate affected communities. Language barriers and the fear stemming from recent immigration policies may prevent many from seeking necessary healthcare or even discussing their health issues within their families.
To combat these issues, community health initiatives and increased engagement from social justice organizations are critical. Advocating for accessible resources and education is essential to empower women of color to recognize symptoms of PMOS and seek timely medical intervention.
Expert opinions suggest that acknowledging the complexities of PMOS and its impact on diverse populations must be a key priority moving forward. Increased funding for research and enhanced healthcare access are vital steps towards fostering better health outcomes for all women, especially those who have been historically marginalized. Addressing systemic barriers can pave the way for more effective treatment approaches and enhanced understanding of this complex syndrome.
By nurturing a culture of awareness, the healthcare community can work towards not only improving diagnosis rates of PMOS among women of color but also ensuring they receive the care and support they deserve.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.